Medicare Enrolled
Dr. Tariq Mahmood, M.D.
Optician · Orange, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mahmood from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mahmood?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mahmood
Dr. Tariq Mahmood is an optician specialist in Orange, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mahmood performed 1,684 Medicare services across 747 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mahmood received a total of $21,133 from 99 pharmaceutical and/or device companies across 1077 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mahmood is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 41% volume in CA
$21,133 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,684
Medicare services
Top 41% in CA for optician
747
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~89 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,133 | $99 | $265 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
295 | $8 | $37 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
154 | $8 | $35 |
| New patient office visit, complex (60-74 min) | 40 | $166 | $386 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
32 | $74 | $231 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
19 | $153 | $408 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $128 | $423 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$21,133
Total received (2018-2024)
Avg $3,019/year across 7 years
Top 9% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
99
Companies
1,077
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,574 (97.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$559 (2.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,637
2023
$3,641
2022
$2,927
2021
$3,384
2020
$2,229
2019
$2,261
2018
$2,054
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$413
Novartis Pharmaceuticals Corporation
$316
Daiichi Sankyo Inc.
$261
Celgene Corporation
$260
PFIZER INC.
$257
Takeda Pharmaceuticals U.S.A., Inc.
$243
Merck Sharp & Dohme LLC
$240
GlaxoSmithKline, LLC.
$239
Janssen Biotech, Inc.
$195
Incyte Corporation
$194
ABBVIE INC.
$183
Alexion Pharmaceuticals, Inc.
$152
SOBI, INC
$151
E.R. Squibb & Sons, L.L.C.
$133
Genentech USA, Inc.
$122
Exelixis Inc.
$110
ARRAY BIOPHARMA INC
$105
GENZYME CORPORATION
$84
BeiGene USA, Inc.
$79
Eisai Inc.
$73
Karyopharm Therapeutics Inc.
$71
Lilly USA, LLC
$59
Boehringer Ingelheim Pharmaceuticals, Inc.
$57
Immunocore Limited
$54
PUMA BIOTECHNOLOGY, INC.
$54
Aveo Pharmaceuticals, Inc.
$50
Gilead Sciences, Inc.
$48
Ipsen Biopharmaceuticals, Inc
$42
EMD Serono, Inc.
$35
ADC Therapeutics America, Inc.
$33
Genmab U.S., Inc.
$32
PharmaEssentia USA Corporation
$32
Tempus AI, Inc
$29
Bayer Healthcare Pharmaceuticals Inc.
$27
RECORDATI_RARE_DISEASES_INC.
$25
Coherus Biosciences Inc.
$24
Kite Pharma, Inc.
$22
Deciphera Pharmaceuticals Inc.
$21
Regeneron Healthcare Solutions, Inc.
$19
Secura Bio, Inc.
$18
ACCORD HEALTHCARE, INC.
$18
SERVIER PHARMACEUTICALS LLC
$17
CSL Behring
$17
Astellas Pharma US Inc
$14
Rigel Pharmaceuticals, Inc.
$10
Top 3 companies account for 21.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,495
Celgene Corporation
$1,312
Incyte Corporation
$1,227
PFIZER INC.
$1,081
E.R. Squibb & Sons, L.L.C.
$849
Pharmacyclics LLC, An AbbVie Company
$795
Amgen Inc.
$786
Janssen Biotech, Inc.
$778
Novartis Pharmaceuticals Corporation
$700
Lilly USA, LLC
$698
Merck Sharp & Dohme Corporation
$687
Merck Sharp & Dohme LLC
$618
GENZYME CORPORATION
$538
Takeda Pharmaceuticals U.S.A., Inc.
$506
Eisai Inc.
$503
GlaxoSmithKline, LLC.
$499
Daiichi Sankyo Inc.
$493
Seagen Inc.
$441
Puma Biotechnology, Inc.
$360
Boehringer Ingelheim Pharmaceuticals, Inc.
$325
Genentech USA, Inc.
$310
Karyopharm Therapeutics Inc.
$303
Exelixis Inc.
$273
Gilead Sciences, Inc.
$271
Alexion Pharmaceuticals, Inc.
$262
ABBVIE INC.
$253
Ipsen Biopharmaceuticals, Inc
$248
BeiGene USA, Inc.
$191
SOBI, INC
$191
EMD Serono, Inc.
$182
Bayer HealthCare Pharmaceuticals Inc.
$177
Astellas Pharma US Inc
$171
Coherus Biosciences Inc.
$169
AbbVie Inc.
$147
Pharmacyclics LLC, an AbbVie Company
$143
Blueprint Medicines Corporation
$143
AbbVie, Inc.
$135
ADC Therapeutics America, Inc.
$117
AMAG Pharmaceuticals, Inc.
$110
Aurobindo Pharma USA, Inc.
$108
ARRAY BIOPHARMA INC
$105
Bayer Healthcare Pharmaceuticals Inc.
$104
Regeneron Healthcare Solutions, Inc.
$101
PUMA BIOTECHNOLOGY, INC.
$95
Kite Pharma, Inc.
$93
EISAI INC.
$93
Stemline Therapeutics Inc.
$89
Genmab U.S., Inc.
$88
Agios Pharmaceuticals, Inc.
$80
NOVARTIS PHARMACEUTICALS CORPORATION
$77
Aveo Pharmaceuticals, Inc.
$76
MEDIVATION FIELD SOLUTIONS LLC
$73
AVEO Pharmaceuticals, Inc.
$67
ImmunoGen, Inc.
$64
Spectrum Pharmaceuticals Inc.
$63
MorphoSys, US Inc.
$59
Immunocore Limited
$54
CSL Behring
$54
Acrotech Biopharma LLC
$52
Epizyme, Inc.,
$49
Deciphera Pharmaceuticals Inc.
$47
ACCORD HEALTHCARE, INC.
$46
Seattle Genetics, Inc.
$45
Verastem, Inc.
$44
Clovis Oncology, Inc.
$42
SERVIER PHARMACEUTICALS LLC
$41
Rigel Pharmaceuticals, Inc.
$38
Janssen Pharmaceuticals, Inc
$36
Taiho Oncology, Inc.
$33
Acceleron Pharma, Inc.
$32
PharmaEssentia USA Corporation
$32
TAIHO ONCOLOGY, INC.
$30
Dova Pharmaceuticals
$30
Tempus AI, Inc
$29
EUSA Pharma (US) LLC
$26
Dendreon Pharmaceuticals LLC
$25
Myriad Genetic Laboratories, Inc.
$25
RECORDATI_RARE_DISEASES_INC.
$25
CTI BioPharma Corp.
$22
Apellis Pharmaceuticals, Inc.
$22
TG THERAPEUTICS, INC.
$21
Immunomedics, Inc.
$21
Foundation Medicine, Inc.
$21
G1 Therapeutics, Inc.
$20
R-Pharm US LLC
$20
SANOFI-AVENTIS U.S. LLC
$20
TG Therapeutics, Inc.
$19
Secura Bio, Inc.
$18
Cumberland Pharmaceuticals, Inc.
$18
Novocure Inc.
$18
Teva Pharmaceuticals USA, Inc.
$18
Advanced Accelerator Applications
$17
Otsuka America Pharmaceutical, Inc.
$17
Sirtex Medical Inc
$17
Servier Pharmaceuticals LLC
$15
Sobi, Inc
$13
Mirati Therapeutics, Inc.
$13
INSYS Therapeutics Inc
$13
Shire North American Group Inc
$12
Top 3 companies account for 19.1% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Afstyla · Alecensa · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · Blincyto · CABOMETYX · CALQUENCE · CAMCEVI · CARVYKTI · COPIKTRA · COSELA · CREON · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Elahere · Empaveli · Enhertu · Epkinly · Erleada · FERAHEME · FOLOTYN · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Folotyn · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Idelvion · Idhifa · Imbruvica · Ixempra · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lupron · Lutathera · MEKINIST · MONJUVI · MVASI · MYCHOICE CDX · MYLOTARG · NERLYNX · NINLARO · NOXAFIL · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · Oncology · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Prolia · QINLOCK · REBLOZYL · RECOTHROM · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · SYNAGIS · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · VPRIV · Vanflyta · Vectibix · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Yescarta · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for optician in CA.
Geographic Context
Opticians within 10 mi
1,034
Per 100K population
32.7
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JOSEPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mahmood is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 9% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mahmood experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mahmood performed 1,133 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mahmood receive payments from pharmaceutical companies?
Yes. Dr. Mahmood received a total of $21,133 from 99 companies across 1,077 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mahmood's costs compare to other opticians in Orange?
Dr. Mahmood's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mahmood) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Orange
Browse opticians in Orange ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology